Security key
207523101
Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB)
CUSIP: 207523101
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Ordinary shares, par value $0.000174
- Total 13F shares
- 10,358,458
- Total 13F value
- $11,684,999
- Share change
- -560,657
- SEC-reported price per share
- $1.11
- Number of holders
- 15
- Value change
- -$631,607
- Number of buys
- 4
- Number of sells
- 7
- Shares outstanding
- 62,516,710
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
15
Top holders
10
CNTB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Connect Biopharma Holdings Ltd SEC filings
Connect Biopharma Holdings Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP 207523101
Recent filing periods:
Ownership snapshot
Top reported holders of CNTB - Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
11%
BlackRock Finance, Inc.
1.8%
ADAGE CAPITAL PARTNERS GP, L.L.C.
1.6%
Kynam Capital Management, LP
1.2%
OCONNOR, A Distinct Business Unit...
0.92%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
11%
|
$6,990,304
6,991,003 shares
|
— | 31 Mar 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
1.8%
|
$1,125,149
1,125,262 shares
|
— | 31 Mar 2023 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
1.6%
|
$1,027,416
1,027,519 shares
|
— | 31 Mar 2023 |
| Kynam Capital Management, LP |
13F
Company
|
1.2%
|
$739,575
739,649 shares
|
— | 31 Mar 2023 |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
Company
|
0.92%
|
$574,148
574,148 shares
|
— | 31 Mar 2023 |
| Ikarian Capital, LLC |
13F
Company
|
0.35%
|
$219,479
219,501 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
10,358,458
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2026 Across Filers
Q1 2026 holders
1
Q2 2023 holders
15
Holder diff
14
| Investor | Q1 2026 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend